Your browser is no longer supported. Please, upgrade your browser.
EGRX Eagle Pharmaceuticals, Inc. monthly Stock Chart
Eagle Pharmaceuticals, Inc.
Index- P/E266.93 EPS (ttm)0.16 Insider Own12.67% Shs Outstand13.67M Perf Week-9.52%
Market Cap594.34M Forward P/E15.28 EPS next Y2.81 Insider Trans0.00% Shs Float10.80M Perf Month-15.40%
Income2.50M PEG242.66 EPS next Q0.24 Inst Own97.80% Short Float19.17% Perf Quarter-14.51%
Sales192.10M P/S3.09 EPS this Y-51.50% Inst Trans-1.35% Short Ratio11.84 Perf Half Y-19.96%
Book/sh13.30 P/B3.23 EPS next Y39.40% ROA0.90% Target Price51.67 Perf Year-23.50%
Cash/sh14.61 P/C2.94 EPS next 5Y1.10% ROE1.40% 52W Range33.80 - 64.94 Perf YTD-28.47%
Dividend- P/FCF18.63 EPS past 5Y20.20% ROI6.50% 52W High-33.82% Beta0.86
Dividend %- Quick Ratio1.80 Sales past 5Y59.30% Gross Margin71.10% 52W Low27.14% ATR2.11
Employees108 Current Ratio1.90 Sales Q/Q-7.60% Oper. Margin7.10% RSI (14)35.07 Volatility7.65% 4.34%
OptionableYes Debt/Eq0.81 EPS Q/Q-133.80% Profit Margin1.30% Rel Volume0.59 Prev Close43.72
ShortableYes LT Debt/Eq0.17 EarningsAug 10 BMO Payout0.00% Avg Volume174.81K Price42.97
Recom2.20 SMA20-10.29% SMA50-9.88% SMA200-17.03% Volume103,000 Change-1.70%
Nov-01-18Downgrade Cantor Fitzgerald Overweight → Neutral
Oct-31-18Downgrade Piper Jaffray Overweight → Neutral
Mar-21-18Reiterated Mizuho Underperform $37 → $40
Nov-09-17Reiterated RBC Capital Mkts Outperform $81 → $75
Sep-06-17Reiterated Mizuho Underperform $40 → $37
Jul-27-17Reiterated RBC Capital Mkts Outperform $94 → $81
Jul-27-17Reiterated Mizuho Underperform $57 → $40
May-09-17Reiterated RBC Capital Mkts Outperform $86 → $94
Jan-09-17Downgrade Mizuho Neutral → Underperform $78 → $64
Nov-16-16Downgrade Mizuho Buy → Neutral $78
Nov-03-16Upgrade Mizuho Neutral → Buy $62 → $78
Nov-03-16Reiterated RBC Capital Mkts Outperform $80 → $93
Oct-26-16Reiterated Mizuho Buy $65 → $62
Aug-16-16Reiterated Mizuho Neutral $47 → $65
Jun-20-16Downgrade Mizuho Buy → Neutral $66 → $47
May-10-16Reiterated RBC Capital Mkts Outperform $94 → $78
Mar-18-16Reiterated Mizuho Buy $81 → $71
Feb-26-16Reiterated Mizuho Buy $112 → $81
Dec-09-15Initiated Mizuho Buy $112
Jul-29-15Reiterated Piper Jaffray Overweight $94 → $119
Aug-10-20 01:30PM  
Aug-03-20 04:30PM  
Jul-17-20 11:47AM  
Jul-09-20 12:00PM  
Jun-27-20 09:28PM  
Jun-10-20 04:08PM  
May-26-20 04:30PM  
May-22-20 04:05PM  
May-14-20 11:50AM  
May-12-20 04:30PM  
May-11-20 12:30PM  
May-08-20 08:41AM  
May-07-20 06:07AM  
May-04-20 06:50AM  
Apr-29-20 04:30PM  
Apr-28-20 12:33PM  
Apr-16-20 05:24PM  
Apr-11-20 09:25AM  
Mar-30-20 06:50AM  
Mar-24-20 02:20AM  
Mar-10-20 07:55AM  
Mar-02-20 08:15AM  
Feb-24-20 12:30PM  
Feb-19-20 04:30PM  
Feb-13-20 07:50AM  
Feb-10-20 09:54AM  
Jan-13-20 06:50AM  
Jan-09-20 08:40AM  
Jan-08-20 10:18AM  
Jan-07-20 09:25AM  
Jan-06-20 06:50AM  
Dec-23-19 06:50AM  
Dec-16-19 06:50AM  
Dec-13-19 02:53PM  
Dec-11-19 11:25AM  
Dec-09-19 06:50AM  
Dec-03-19 08:45AM  
Nov-21-19 07:49AM  
Nov-20-19 06:50AM  
Nov-14-19 06:50AM  
Nov-12-19 08:15AM  
Nov-09-19 02:26PM  
Nov-05-19 10:31AM  
Oct-31-19 04:30PM  
Oct-28-19 08:02AM  
Oct-17-19 09:28AM  
Oct-07-19 06:50AM  
Oct-02-19 02:39PM  
Sep-24-19 11:30AM  
Sep-23-19 04:30PM  
Sep-10-19 07:29AM  
Sep-04-19 08:40AM  
Aug-30-19 01:49PM  
Aug-28-19 04:30PM  
Aug-20-19 04:47PM  
Aug-18-19 10:21AM  
Aug-14-19 10:29AM  
Aug-09-19 06:23AM  
Aug-08-19 08:45AM  
Aug-05-19 06:50AM  
Aug-01-19 10:33AM  
Jul-29-19 04:30PM  
Jul-26-19 07:54AM  
Jul-03-19 01:59PM  
May-31-19 03:07PM  
May-28-19 04:30PM  
May-15-19 06:34PM  
May-09-19 08:43PM  
May-08-19 06:00AM  
May-07-19 12:23PM  
Apr-30-19 10:32AM  
Apr-29-19 06:50AM  
Apr-22-19 09:48AM  
Apr-15-19 06:50AM  
Eagle Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing injectable products primarily in the critical care and oncology areas in the United States. The company offers Argatroban, an anti-coagulant thrombin inhibitor for heparin-induced thrombocytopenia; Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also includes EP-4104, a dantrolene sodium for exertional heat stroke, as well as to treat organophosphate exposure; EP-5101 (PEMFEXY) for lung cancer and mesothelioma; EGL-5385-C-1701 (fulvestrant) for breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has a strategic collaboration with Tyme Technologies, Inc. to advance oral SM-88 for the treatment of patients with cancer. Eagle Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Woodcliff Lake, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Hudson Executive Capital LPDirectorOct 25Sale63.5715,437981,302732,777Oct 28 04:40 PM
Hudson Executive Capital LPDirectorOct 24Sale62.531,49493,412748,214Oct 28 04:40 PM
Hudson Executive Capital LPDirectorOct 23Sale62.5820012,516749,708Oct 23 06:58 PM
Hudson Executive Capital LPDirectorOct 22Sale62.686,567411,618749,908Oct 23 06:58 PM
Hudson Executive Capital LPDirectorOct 21Sale62.563,849240,791756,475Oct 23 06:58 PM
Hudson Executive Capital LPDirectorOct 18Sale62.611,600100,174760,324Oct 18 05:29 PM
Hudson Executive Capital LPDirectorOct 17Sale62.5813,842866,196761,924Oct 18 05:29 PM
Hudson Executive Capital LPDirectorOct 16Sale62.501026,375775,766Oct 18 05:29 PM
Hudson Executive Capital LPDirectorOct 15Sale62.633,909244,836775,868Oct 15 06:24 PM
Hudson Executive Capital LPDirectorOct 11Sale60.3916,300984,419779,777Oct 15 06:24 PM
Hudson Executive Capital LPDirectorOct 10Sale60.167,829471,002796,077Oct 15 06:24 PM
Hudson Executive Capital LPDirectorOct 08Sale60.031,55893,520803,906Oct 09 04:13 PM
Hudson Executive Capital LPDirectorOct 07Sale60.114,901294,600805,464Oct 09 04:13 PM
Hudson Executive Capital LPDirectorSep 17Sale60.001006,000810,365Sep 19 04:13 PM
Hudson Executive Capital LPDirectorSep 12Sale60.0720012,014810,465Sep 13 04:43 PM
Hudson Executive Capital LPDirectorSep 11Sale60.061,11266,785810,665Sep 13 04:43 PM